Christina Maida is an Investment Analyst and Trader working alongside Mr. Isaly to execute Exome’s worldwide healthcare investing strategy. Ms. Maida has been with Exome since its inception in June 2018. In addition to overseeing trading operations, she focuses on life science tools and medical devices in the United States and Europe. Ms. Maida received her B.A. from Princeton University and her Master’s degree from New York University.